Inspire Corporate Bond ETF (IBD)
| Assets | $471.21M |
| Expense Ratio | 0.41% |
| PE Ratio | n/a |
| Shares Out | 19.90M |
| Dividend (ttm) | $1.01 |
| Dividend Yield | 4.25% |
| Ex-Dividend Date | May 22, 2026 |
| Payout Frequency | Monthly |
| Payout Ratio | n/a |
| Volume | 39,779 |
| Open | 23.83 |
| Previous Close | 23.94 |
| Day's Range | 23.79 - 23.84 |
| 52-Week Low | 23.51 |
| 52-Week High | 24.85 |
| Beta | 0.19 |
| Holdings | 251 |
| Inception Date | Jul 10, 2017 |
About IBD
Fund Home PageThe Inspire Corporate Bond ETF (IBD) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks an equally weighted index of bonds issued by S&P 500-component companies that meet biblically responsible investing standards according to the Issuer. IBD was launched on Jul 10, 2017 and is issued by Inspire.
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| May 22, 2026 | $0.0776 | May 27, 2026 |
| Apr 24, 2026 | $0.0788 | Apr 29, 2026 |
| Mar 27, 2026 | $0.0932 | Apr 1, 2026 |
| Feb 24, 2026 | $0.0779 | Mar 2, 2026 |
| Jan 27, 2026 | $0.0592 | Feb 2, 2026 |
| Dec 17, 2025 | $0.121 | Dec 24, 2025 |
Performance
IBD had a total return of 4.04% in the past year, including dividends. Since the fund's inception, the average annual return has been 2.16%.
News
AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week®
AbbVie presents 18 abstracts in Crohn's disease and ulcerative colitis Breadth of data from real-world evidence and clinical trials reinforce risankizumab and upadacitinib efficacy, safety profile, an...
Inspire Investing Announces Lower Expense Ratios on 5 Faith-Based ETFs
BOISE, Idaho, April 28, 2026 /PRNewswire/ -- Inspire Investing, the world's largest provider of Christian ETFs, reported expense ratio reductions on five of its exchange traded funds. These reductions...
Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases
LA JOLLA, Calif.--(BUSINESS WIRE)--As people live longer than ever before, the incidence of aging-related, chronic diseases is on the rise, severely impacting quality of life and placing an unpreceden...
Inspire ETFs Reports Expense Ratio Reductions for 7 Funds
Inspire Investing has announced fee reductions on seven of its biblically responsible, faith-based ESG ETFs BOISE, Idaho , May 2, 2022 /PRNewswire/ -- Inspire Investing, the world's largest provider o...